172 related articles for article (PubMed ID: 33425743)
41. Adjuvant radiation for WHO grade II and III intracranial meningiomas: insights on survival and practice patterns from a National Cancer Registry.
Brown DA; Goyal A; Kerezoudis P; Alvi MA; Himes BT; Bydon M; Van Gompel JJ; Chaichana KL; Quiñones-Hinojosa A; Burns TC; Yan E; Parney IF
J Neurooncol; 2020 Sep; 149(2):293-303. PubMed ID: 32860156
[TBL] [Abstract][Full Text] [Related]
42. Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma.
Rydzewski NR; Lesniak MS; Chandler JP; Kalapurakal JA; Pollom E; Tate MC; Bloch O; Kruser T; Dalal P; Sachdev S
Cancer; 2018 Feb; 124(4):734-742. PubMed ID: 29131312
[TBL] [Abstract][Full Text] [Related]
43. Clinical and histopathological predictors of outcome in malignant meningioma.
Maier AD; Bartek J; Eriksson F; Ugleholdt H; Juhler M; Broholm H; Mathiesen TI
Neurosurg Rev; 2020 Apr; 43(2):643-653. PubMed ID: 30868425
[TBL] [Abstract][Full Text] [Related]
44. Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome.
Biczok A; Jungk C; Egensperger R; von Deimling A; Suchorska B; Tonn JC; Herold-Mende C; Schichor C
J Neurooncol; 2019 Dec; 145(3):469-477. PubMed ID: 31713016
[TBL] [Abstract][Full Text] [Related]
45. Neurosurgical follow-up and treatment of a series of 26 WHO grade III meningiomas.
Güdük M; Ekşi MŞ; Bozkurt B; Usseli Mİ; Erşen Danyeli A; Pamir MN
J Clin Neurosci; 2021 Sep; 91():219-225. PubMed ID: 34373031
[TBL] [Abstract][Full Text] [Related]
46. Radiologic Response and Disease Control of Recurrent Intracranial Meningiomas Treated With Reirradiation.
Lin AJ; Hui C; Dahiya S; Lu HC; Kim AH; Campian JL; Tsien C; Zipfel GJ; Rich KM; Chicoine M; Huang J
Int J Radiat Oncol Biol Phys; 2018 Sep; 102(1):194-203. PubMed ID: 29970312
[TBL] [Abstract][Full Text] [Related]
47. Prognostic factors effective on survival of patients with glioblastoma: Anadolu Medical Center experience.
Guden M; Ayata HB; Ceylan C; Kilic A; Engin K
Indian J Cancer; 2016; 53(3):382-386. PubMed ID: 28244465
[TBL] [Abstract][Full Text] [Related]
48. Anaplastic Meningioma: Clinical Characteristics, Prognostic Factors and Survival Outcome.
Seo DO; Song SW; Kim YH; Hong CK; Kim JH
Brain Tumor Res Treat; 2022 Oct; 10(4):244-254. PubMed ID: 36347639
[TBL] [Abstract][Full Text] [Related]
49. World Health Organization Grade III Meningiomas: A Retrospective Study at an Academic Medical Center.
Sá-Marta E; Alves JL; Rebelo O; Barbosa M
World Neurosurg; 2021 May; 149():e877-e893. PubMed ID: 33516862
[TBL] [Abstract][Full Text] [Related]
50. Extent of resection and survival outcomes in World Health Organization grade II meningiomas.
Soni P; Davison MA; Shao J; Momin A; Lopez D; Angelov L; Barnett GH; Lee JH; Mohammadi AM; Kshettry VR; Recinos PF
J Neurooncol; 2021 Jan; 151(2):173-179. PubMed ID: 33205354
[TBL] [Abstract][Full Text] [Related]
51. Grade II meningiomas and Gamma Knife radiosurgery: analysis of success and failure to improve treatment paradigm.
Valery CA; Faillot M; Lamproglou I; Golmard JL; Jenny C; Peyre M; Mokhtari K; Mazeron JJ; Cornu P; Kalamarides M
J Neurosurg; 2016 Dec; 125(Suppl 1):89-96. PubMed ID: 27903189
[TBL] [Abstract][Full Text] [Related]
52. Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma.
Hemmati SM; Ghadjar P; Grün A; Badakhshi H; Zschaeck S; Senger C; Acker G; Misch M; Budach V; Kaul D
Radiat Oncol; 2019 Sep; 14(1):160. PubMed ID: 31477146
[TBL] [Abstract][Full Text] [Related]
53. Prognostic Factors, Survival, and Treatment for Intracranial World Health Organization Grade II Chordoid Meningiomas and Clear-Cell Meningiomas.
Zhang GJ; Zhang YS; Zhang GB; Yan XJ; Li CB; Zhang LW; Li D; Wu Z; Zhang JT
World Neurosurg; 2018 Sep; 117():e57-e66. PubMed ID: 29859361
[TBL] [Abstract][Full Text] [Related]
54. Relevance of Simpson grading system and recurrence-free survival after surgery for World Health Organization Grade I meningioma.
Nanda A; Bir SC; Maiti TK; Konar SK; Missios S; Guthikonda B
J Neurosurg; 2017 Jan; 126(1):201-211. PubMed ID: 27058201
[TBL] [Abstract][Full Text] [Related]
55. Efficacy of Bevacizumab in High-Grade Meningiomas: A Retrospective Clinical Study.
Bai X; Liu X; Wen J
Neuropsychiatr Dis Treat; 2022; 18():1619-1627. PubMed ID: 35968510
[TBL] [Abstract][Full Text] [Related]
56. Clinical outcome of surgically treated low-grade gliomas: a retrospective analysis of a single institute.
Turkoglu E; Gurer B; Sanli AM; Dolgun H; Gurses L; Oral NA; Donmez T; Sekerci Z
Clin Neurol Neurosurg; 2013 Dec; 115(12):2508-13. PubMed ID: 24225484
[TBL] [Abstract][Full Text] [Related]
57. Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma.
Bruna J; Brell M; Ferrer I; Gimenez-Bonafe P; Tortosa A
Neuropathology; 2007 Apr; 27(2):114-20. PubMed ID: 17494511
[TBL] [Abstract][Full Text] [Related]
58. Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?
Góes P; Santos BFO; Suzuki FS; Salles D; Stávale JN; Cavalheiro S; de Paiva Neto MA
J Neurooncol; 2018 Apr; 137(2):331-336. PubMed ID: 29270884
[TBL] [Abstract][Full Text] [Related]
59. Long-Term Outcomes of Newly Diagnosed Resected Atypical Meningiomas and the Role of Adjuvant Radiotherapy.
Zhi M; Girvigian MR; Miller MJ; Chen JC; Schumacher AJ; Rahimian J; Lodin K
World Neurosurg; 2019 Feb; 122():e1153-e1161. PubMed ID: 30447464
[TBL] [Abstract][Full Text] [Related]
60. Long-Term Follow-Up, Treatment Strategies, Functional Outcome, and Health-Related Quality of Life after Surgery for WHO Grade 2 and 3 Intracranial Meningiomas.
Pettersson-Segerlind J; Fletcher-Sandersjöö A; von Vogelsang AC; Persson O; Kihlström Burenstam Linder L; Förander P; Mathiesen T; Edström E; Elmi-Terander A
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
